19
17
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T75103 | CD19 CAR mRNA | ||
CD19 CAR mRNA is designed to express the CD19 chimeric antigen receptor (CAR) protein, pivotal in chimeric antigen receptor T cell (CAR-CD19) immunotherapy. This receptor targets CD19, a membrane antigen crucial for B ce... | |||
T75104 | CD19 CAR circRNA | ||
CD19 CAR circRNA, expressing CD19 car protein, is utilized in chimeric antigen receptor T cell immunotherapy (CAR-CD19). This compound involves a chimeric antigen receptor, CD19, a CD molecule present on B cells (i.e., l... | |||
T75114 | CD19 car mRNA-LNP | ||
CD19 car mRNA-LNP, a lipid nanoparticle (LNP) encapsulating CD19 car mRNA, is instrumental in assessing RNA delivery, translation efficacy, and cell viability among other applications. This compound is pivotal for chimer... | |||
T75115 | CD19 car circRNA-LNP | ||
CD19 car circRNA-LNP, a lipid nanoparticle containing CD19 car circRNA, is designed for applications in RNA delivery, translation efficiency, and cell viability assessment. This compound is utilized in chimeric antigen r... | |||
T80620 | Anti-Mouse CD19 Antibody (1D3) | ||
Anti-Mouse CD19 Antibody (1D3) is an IgG2a isotype inhibitor targeting mouse CD19. | |||
T82466 | Englumafusp alfa | RG6076,CD19-4-1BBL,RO7227166 | |
Englumafusp alfa (CD19-4-1BBL; RO7227166) is a fusion protein combining a CD19-specific antibody domain with trimerized extracellular domains of human 4-1BBL, designed to induce CD19-specific 4-1BB cross-linking on the s... | |||
T76713 | Inebilizumab | MEDI 551,MT-0551,16C4-aFuc,VIB-0551 | Others |
Inebilizumab is a humanized anti-CD19 monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used to treat a range of autoimmune diseases associated with CD19... | |||
T77135 | Tafasitamab | MOR00208,XmAb5574,Tafasitamab-cxix | Apoptosis , Immunology/Inflammation related |
Tafasitamab (XmAb5574) is an FC-modified humanized monoclonal antibody targeting the human B-cell surface antigen CD19 for the study of diffuse large B-cell lymphoma. | |||
TQ0291 | Firategrast | SB 683699 | Integrin |
Firategrast (SB 683699) is an orally active and specific α4β1/α4β7 integrin antagonist.Firategrast reduces the transport of lymphocytes into the central nervous system (CNS) and decreases multiple sclerosis (MS) activity... | |||
T9901A-013 | Coltuximab | ||
Coltuximab is a humanized monoclonal antibody against CD19, a modulator of the B lymphocyte antigen CD19. | |||
T81042 | Taplitumomab paptox | ||
Taplitumomab paptox is an anti-CD19 monoclonal antibody utilized in cancer research. | |||
T80981 | Tisagenlecleucel | CTL019 | |
Tisagenlecleucel (CTL019), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, selectively targets and eradicates CD19-expressing B cells, and is utilized in the study of refractory aggressive diffuse... | |||
T76854 | Loncastuximab tesirine | ||
Loncastuximab tesirine, a human cluster of differentiation 19 (CD19)-directed antibody-drug conjugate (ADC), binds to CD19 on the cell membrane, facilitating rapid internalization and inducing cell apoptosis. This mechan... | |||
T78317 | Blinatumomab | Anatumomab | |
Blinatumomab (formerly known as Anatumomab) is a bispecific monoclonal antibody that specifically targets the CD19 antigen on B cells and is utilized in the study of acute lymphoblastic leukemia [1]. | |||
T80606 | Duvortuxizumab | MGD 011 | |
Duvortuxizumab (MGD 011) is a chimeric, humanized immunoglobulin (IG) antibody that specifically targets CD19 and CD3E receptors [1]. | |||
T81624 | Obexelimab | XmAb5871 | |
Obexelimab (XmAb5871) is a humanized Fc-engineered anti-CD19 antibody with enhanced affinity for FcγRIIb, utilized in the study of autoimmune diseases [1]. | |||
T77070 | Loncastuximab | ||
Loncastuximab (RB4v1.2), an anti-CD19 monoclonal antibody, exhibits antitumor properties and holds potential for treating non-Hodgkin's lymphoma (NHL), specifically diffuse large B-cell lymphoma (DLBCL) [1] [2]. | |||
T81829 | MDX-1342 | ||
MDX-1342, a fully human monoclonal antibody (HuMAb), targets the CD19 membrane receptor with high specificity and affinity. It exhibits antibody-dependent cellular cytotoxicity (ADCC) and is utilized in researching B-lym... | |||
T76801 | Denintuzumab | ||
Denintuzumab (hBU 12), a recombinant humanized anti-CD19 monoclonal antibody, serves as the antibody component in the synthesis of antibody-drug conjugates (ADC), notably Denintuzumab Mafodotin (SGN-CD19A). This ADC is u... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-05427 | CD19 Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
CD19 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 56.8 kDa and the accession number is P15391-2. | |||
TMPY-01949 | CD19 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
CD19 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 31.6 kDa and the accession number is P15391-1. | |||
TMPY-01741 | CD19 Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells |
CD19 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 31.1 kDa and the accession number is P25918. | |||
TMPY-05530 | CD19 Protein, Cynomolgus/Rhesus, Recombinant (His), Biotinylated | Cynomolgus,Rhesus | HEK293 Cells |
CD19 Protein, Cynomolgus/Rhesus, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 31.4 kDa and the accession number is XP_005591597.1. | |||
TMPY-05540 | CD19 Protein, Mouse, Recombinant (His), Biotinylated | Mouse | HEK293 Cells |
CD19 Protein, Mouse, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 31 kDa and the accession number is P25918. | |||
TMPY-05127 | CD19 Protein, Human, Recombinant (His), Biotinylated | Human | HEK293 Cells |
CD19 Protein, Human, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 31.6 kDa and the accession number is P15391. | |||
TMPY-06681 | CD19 Protein, Rat, Recombinant (His) | Rat | HEK293 Cells |
CD19 Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 31.11 kDa and the accession number is NP_001013255.2. | |||
TMPY-04729 | CD19 Protein, Cynomolgus, Rhesus, Recombinant (hFc) | Cynomolgus,Rhesus | HEK293 Cells |
CD19 Protein, Cynomolgus, Rhesus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 57 kDa and the accession number is XP_005591597.1. | |||
TMPY-05420 | CD19 Protein, Cynomolgus, Rhesus, Recombinant (His) | Cynomolgus,Rhesus | HEK293 Cells |
CD19 Protein, Cynomolgus, Rhesus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 31.4 kDa and the accession number is XP_005591597.1. | |||
TMPJ-00329 | CD19 Protein, Rhesus macaque, Recombinant (hFc) | Rhesus | HEK293 Cells |
CD19 is a single-pass type I membrane protein containing 2 Ig-like C2-type (immunoglobulin-like) domains. CD19 is expressed on follicular dendritic cells and B cells. In fact, it is present on B cells from earliest recog... | |||
TMPY-06320 | CD19 Protein, Human, Recombinant (hFc & Avi), Biotinylated | Human | HEK293 Cells |
CD19 Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with hFc and Avi tag. The predicted molecular weight is 58.65 kDa and the accession number is NP_001171569.1. | |||
TMPY-06755 | CD19 Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 Cells |
CD19 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 33.37 kDa and the accession number is P15391-1. | |||
TMPK-00327 | CD19 Protein, Cynomolgus/Rhesus macaque, Recombinant (His) | Cynomolgus,Rhesus | HEK293 Cells |
CD19 is a 95 kDa transmembrane glycoprotein that plays a central role in B cell activation and humoral immune responses.Functions as coreceptor for the B-cell antigen receptor complex (BCR) on B-lymphocytes. Decreases th... | |||
TMPK-00100 | CD7 Protein (Primary Amine Labeling), Mouse, Recombinant (hFc), Biotinylated | Mouse | HEK293 Cells |
CD7, also known as Leu-9, is an approximately 40 kDa glycosylated and palmitoylated transmembrane protein in the immunoglobulin superfamily.CD7 is expressed on T cells, NK cells , myeloid progenitor cells, and CD19 B pro... | |||
TMPK-00129 | CD7 Protein, Human, Recombinant (His & Avi) | Human | HEK293 Cells |
CD7, also known as Leu-9, is an approximately 40 kDa glycosylated and palmitoylated transmembrane protein in the immunoglobulin superfamily.CD7 is expressed on T cells, NK cells , myeloid progenitor cells, and CD19 B pro... | |||
TMPK-00128 | CD7 Protein, Human, Recombinant (His & Avi), PE-Labeled | Human | HEK293 Cells |
CD7, also known as Leu-9, is an approximately 40 kDa glycosylated and palmitoylated transmembrane protein in the immunoglobulin superfamily.CD7 is expressed on T cells, NK cells , myeloid progenitor cells, and CD19 B pro... | |||
TMPY-02810 | Ninjurin-1 Protein, Rat, Recombinant (hFc) | Rat | HEK293 Cells |
Ninjurin-1, also known as NINJ1, is a member of the Ninjurin family of transmembrane (TM) proteins. It is expressed in CD19(+) CD10(+) B-cell progenitor cells and higher levels in B-lineage acute lymphoblastic leukemia c... |